Estradiol (E2)

DRUG7 trials

Sponsors

University of Michigan, Organon and Co, Tel-Aviv Sourasky Medical Center, University of British Columbia, Martin Blomberg Jensen

Conditions

Anovulatory InfertilityBlood CoagulationBone MarkersCerebral Blood FlowCerebral Blood Flow RegulationCoagulation FactorsContraceptionExercise

Phase 2

A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

CompletedNCT01709318

Organon and CoContraception

Start: 2012-12-12End: 2013-10-22Updated: 2024-05-28

COMPASS - COpenhagen MenoPAuSe Study

RecruitingNCT07254429

Martin Blomberg JensenBone Markers, Menopausal Osteoporosis

Start: 2025-10-02End: 2028-05-01Target: 192Updated: 2026-03-02

Phase 3

Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)

WithdrawnNCT01723579

Organon and CoContraception

Start: 2013-07-31End: 2015-05-31Updated: 2022-02-16

Unknown Phase

Early Menopause Hormone Treatment and Cognition

CompletedNCT01046643

University of MichiganMenopausal Syndrome

Start: 2010-05-31End: 2012-03-31Updated: 2014-05-19

Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study

CompletedNCT07145281

Tel-Aviv Sourasky Medical CenterBlood Coagulation, Coagulation Factors, Gender Dysphoria, Adult +3

Start: 2022-11-10End: 2024-11-10Updated: 2025-08-28

The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

Not yet recruitingNCT07212712

University of British ColumbiaCerebral Blood Flow, Cerebral Blood Flow Regulation, Exercise +2

Start: 2026-04-01End: 2027-12-31Target: 50Updated: 2026-02-10

Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction

CompletedNCT07398924

Yuzuncu Yil UniversityAnovulatory Infertility, Female Infertility, Unexplained Infertility

Start: 2022-01-06End: 2023-06-23Updated: 2026-02-10